These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Quinolone-resistant mutations of DNA gyrase increase sensitivity to acriflavine. Funatsuki K, Tanaka R, Inagaki S, Konno H, Katoh K, Nakamura H. Biol Pharm Bull; 1998 Jul; 21(7):667-72. PubMed ID: 9703246 [Abstract] [Full Text] [Related]
6. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Ito H, Yoshida H, Bogaki-Shonai M, Niga T, Hattori H, Nakamura S. Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012 [Abstract] [Full Text] [Related]
8. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling. Aleixandre V, Urios A, Herrera G, Blanco M. Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316 [Abstract] [Full Text] [Related]
9. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding. Mustaev A, Malik M, Zhao X, Kurepina N, Luan G, Oppegard LM, Hiasa H, Marks KR, Kerns RJ, Berger JM, Drlica K. J Biol Chem; 2014 May 02; 289(18):12300-12. PubMed ID: 24497635 [Abstract] [Full Text] [Related]
11. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Cullen ME, Wyke AW, Kuroda R, Fisher LM. Antimicrob Agents Chemother; 1989 Jun 02; 33(6):886-94. PubMed ID: 2548439 [Abstract] [Full Text] [Related]
13. Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity. Aubry A, Pan XS, Fisher LM, Jarlier V, Cambau E. Antimicrob Agents Chemother; 2004 Apr 02; 48(4):1281-8. PubMed ID: 15047530 [Abstract] [Full Text] [Related]
14. Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance. Kim H, Nakajima C, Yokoyama K, Rahim Z, Kim YU, Oguri H, Suzuki Y. Antimicrob Agents Chemother; 2011 Aug 02; 55(8):3661-7. PubMed ID: 21646485 [Abstract] [Full Text] [Related]
15. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis. Onodera Y, Tanaka M, Sato K. J Antimicrob Chemother; 2001 Apr 02; 47(4):447-50. PubMed ID: 11266418 [Abstract] [Full Text] [Related]
16. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. Chen CR, Malik M, Snyder M, Drlica K. J Mol Biol; 1996 May 17; 258(4):627-37. PubMed ID: 8636997 [Abstract] [Full Text] [Related]
17. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins. Pan XS, Yague G, Fisher LM. Antimicrob Agents Chemother; 2001 Nov 17; 45(11):3140-7. PubMed ID: 11600369 [Abstract] [Full Text] [Related]
18. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene. Kumagai Y, Kato JI, Hoshino K, Akasaka T, Sato K, Ikeda H. Antimicrob Agents Chemother; 1996 Mar 17; 40(3):710-14. PubMed ID: 8851598 [Abstract] [Full Text] [Related]
19. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. Blanche F, Cameron B, Bernard FX, Maton L, Manse B, Ferrero L, Ratet N, Lecoq C, Goniot A, Bisch D, Crouzet J. Antimicrob Agents Chemother; 1996 Dec 17; 40(12):2714-20. PubMed ID: 9124828 [Abstract] [Full Text] [Related]